semaglutide news oct 26 2025 Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy : Shots Novo Nordisk faces 'must-win' battle

The FDA significantly increased its compliance activity surrounding advertising for compounded drugs in 2025, and recent remarks from an FDA official highlighted the agencys concerns about claims that state or imply the equivalence of compounded drugs to approved drugs.

| As part of its investor day on Thursday, Cigna's Evernorth arm announced an expansion to its GLP-1 management solution as well as the launch of a new behavioral health-focused medical group.

Mastering subcutaneous injection technique in the upper thigh ensures consistent drug absorption and reduces injection-site discomfort

Achieve your weight loss goals with semaglutide treatments in Huntington Beach

GLP-1 boosters represent the next generation of personalized weight loss therapy, allowing patients to optimize their metabolic response without switching medications entirely